CORDENPHARMA LISBON (PT)

Core Capabilities

  • >> Manufacturer of Oral Solid Dosage (OSD) forms (tablets, capsules, sachets & bulk powder)
  • >> Manufacturer of non-sterile liquid dosage forms
  • >> Extensive primary & secondary packaging capabilities and capacity
  • >> Full range of services including manufacturing of clinical & commercial products and pharma-logistics

COMPLIANCE

  • >> Infarmed - first inspection 2016
  • >> US FDA - first inspection 2021
  • >> Brazil (ANVISA) - first inspection 2018

Facility Legacy

CordenPharma Lisbon is an expert manufacturer of solid oral dosage forms and non-sterile liquid drug products, offering a full range of manufacturing services from phase I-III and commercial scale manufacturing, to packaging and pharma-logistics for a global market.

As a former Vifor Pharma operations site, CordenPharma Lisbon brings over 52 years of experience to CordenPharma’s full-service CDMO platform. The site is inspected by Inframed, FDA and ANVISA.

HISTORY

  • >> 1970 - Foundation
  • >> 2002 - Expansion of the site
  • >> 2009 - Integration into Vifor Pharma
  • >> 2018 - Second Production building constructed
  • >> 2021 - FDA certification
  • >> 2022 - Acquired by ICIG to become Corden Pharma Lisbon S.A.

Managing Director

Martin Walde

OM Pharma S.A. (to be renamed Corden Pharma Lisbon S.A.)

R. da Indústria, 2
Quinta Grande
2610-088 Amadora
(Apartado 60 001 · 2701-951 Amadora)
Lisboa, Portugal

Phone: +351 21 470 85 00
Fax: +351 21 470 85 06

Email Human Resources